The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Modulation of lipid metabolism associated with response to metronomic capecitabine plus camrelizumab in patients with refractory gastrointestinal cancer: A prospective, single-center, exploratory trial.
 
Chenfei Zhou
No Relationships to Disclose
 
Yuanyuan Yin
No Relationships to Disclose
 
Chengfang Shangguan
No Relationships to Disclose
 
Min Shi
No Relationships to Disclose
 
Qu Cai
No Relationships to Disclose
 
Jun Ji
No Relationships to Disclose
 
Xuekun Zhang
No Relationships to Disclose
 
Yan Sun
No Relationships to Disclose
 
Sander S.M. Rensen
No Relationships to Disclose
 
Steven W.M. Olde Damink
No Relationships to Disclose
 
Zhenggang Zhu
No Relationships to Disclose
 
Rong Zeng
No Relationships to Disclose
 
Jun Zhang
No Relationships to Disclose